Life-or-death decisions by the Bcl-2 protein family.
By Jerry M. Adams, Suzanne Cory. TIBS -Trends in Biochemical Sciences. Regular ed, 2001
943 citations recorded by the source corpus.
Subfields: Epidemiology, Molecular Biology
View Paper: https://www.semanticscholar.org/paper/68269aa5dfd6949e604bad95c859a343b30d57f6
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Epidemiology
In Molecular Biology
Citations in the corpus
- Mechanisms of ischemic brain damage. (2008, neutral): “Unlike Bax and Bak, Bid, Bad and Bim do not have the ability to directly mediate cytochrome c release by forming a pore.”
- The role of mitochondria in apoptosis. (2008, background): “The pro-apoptotic members can be divided into two groups (22, 23): those with BH1, BH2 and BH3 domains, such as Bax and Bak, and”
- Coupling endoplasmic reticulum stress to the cell death program (2004, background): “, Bad, Bid, Bim, Bik).(112,113) On activation, the proapoptotic Bax and Bak”
- Chondrocyte Apoptosis in the Pathogenesis of Osteoarthritis (2015, background): “Bcl-2 family proteins can be readily heterodimerized by protein-protein interactions between pro- and anti-apoptotic Bcl-2 family members, which determine whether cell survival or the apoptosis signal proceed [25,26].”
- OPA1 controls apoptotic cristae remodeling independently from mitochondrial fusion. (2006, positive): “Proteins of the BCL-2 family control the release of cytochrome c from mitochondria required for the activation of effector caspases (Adams and Cory, 2001).”